Portfolio company
Spark BioPharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops small-molecule therapeutics using a phenotypic discovery platform for pharmaceutical partners treating cancer, inflammation and immune disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PhoreMost
This biopharmaceutical company develops a phenotypic screening platform to identify new drug targets for pharmaceutical and biotechnology partners in oncology and inflammation.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Ribometrix
The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.
BCI Pharma
This biotech company develops selective kinase inhibitors and chemical libraries for pharmaceutical partners to treat cancer, inflammation and women's health conditions.
Forward Therapeutics
The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.
IFM Therapeutics
The company develops small molecule medicines targeting the innate immune system to treat patients with inflammatory diseases and cancer.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
